Clinical trial
Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese…
NCT00481923 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00481923 |
|---|---|
| Title | Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients |
| Official title | A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose (20 mg/Day), 3-Month, Multicenter Study of the Energy Intake Effects and Safety of SR141716 With or Without Hypocaloric Diet in Obese Patients |
| Acronym | REBA |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | rimonabant (SR141716) |
| Enrollment | 156 |
| Start date | May 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Jun 4, 2007 |
| Last update posted | Apr 20, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: